Cargando…

KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy

ABSTRACT. -associated retinopathy or “cone dystrophy with supernormal rod responses” is an autosomal recessive cone-rod dystrophy with pathognomonic ERG findings. This gene encodes Kv8.2, a voltage-gated potassium channel subunit that acts as a modulator by shifting the activation range of the K(+)...

Descripción completa

Detalles Bibliográficos
Autores principales: Guimaraes, Thales A. C. De, Georgiou, Michalis, Robson, Anthony G., Michaelides, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446039/
https://www.ncbi.nlm.nih.gov/pubmed/32441199
http://dx.doi.org/10.1080/13816810.2020.1766087
_version_ 1783574098395267072
author Guimaraes, Thales A. C. De
Georgiou, Michalis
Robson, Anthony G.
Michaelides, Michel
author_facet Guimaraes, Thales A. C. De
Georgiou, Michalis
Robson, Anthony G.
Michaelides, Michel
author_sort Guimaraes, Thales A. C. De
collection PubMed
description ABSTRACT. -associated retinopathy or “cone dystrophy with supernormal rod responses” is an autosomal recessive cone-rod dystrophy with pathognomonic ERG findings. This gene encodes Kv8.2, a voltage-gated potassium channel subunit that acts as a modulator by shifting the activation range of the K(+) channels in photoreceptor inner segments. Currently, no treatment is available for the condition. However, there is a lack of prospective long-term data in large molecularly confirmed cohorts, which is a prerequisite for accurate patient counselling/prognostication, to identify an optimal window for intervention and outcome measures, and ultimately to design future therapy trials. Herein we provide a detailed review of the clinical features, retinal imaging, electrophysiology and psychophysical studies, molecular genetics, and briefly discuss future prospects for therapy trials.
format Online
Article
Text
id pubmed-7446039
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-74460392020-09-14 KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy Guimaraes, Thales A. C. De Georgiou, Michalis Robson, Anthony G. Michaelides, Michel Ophthalmic Genet Reviews ABSTRACT. -associated retinopathy or “cone dystrophy with supernormal rod responses” is an autosomal recessive cone-rod dystrophy with pathognomonic ERG findings. This gene encodes Kv8.2, a voltage-gated potassium channel subunit that acts as a modulator by shifting the activation range of the K(+) channels in photoreceptor inner segments. Currently, no treatment is available for the condition. However, there is a lack of prospective long-term data in large molecularly confirmed cohorts, which is a prerequisite for accurate patient counselling/prognostication, to identify an optimal window for intervention and outcome measures, and ultimately to design future therapy trials. Herein we provide a detailed review of the clinical features, retinal imaging, electrophysiology and psychophysical studies, molecular genetics, and briefly discuss future prospects for therapy trials. Taylor & Francis 2020-05-22 /pmc/articles/PMC7446039/ /pubmed/32441199 http://dx.doi.org/10.1080/13816810.2020.1766087 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Guimaraes, Thales A. C. De
Georgiou, Michalis
Robson, Anthony G.
Michaelides, Michel
KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy
title KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy
title_full KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy
title_fullStr KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy
title_full_unstemmed KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy
title_short KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy
title_sort kcnv2 retinopathy: clinical features, molecular genetics and directions for future therapy
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446039/
https://www.ncbi.nlm.nih.gov/pubmed/32441199
http://dx.doi.org/10.1080/13816810.2020.1766087
work_keys_str_mv AT guimaraesthalesacde kcnv2retinopathyclinicalfeaturesmoleculargeneticsanddirectionsforfuturetherapy
AT georgioumichalis kcnv2retinopathyclinicalfeaturesmoleculargeneticsanddirectionsforfuturetherapy
AT robsonanthonyg kcnv2retinopathyclinicalfeaturesmoleculargeneticsanddirectionsforfuturetherapy
AT michaelidesmichel kcnv2retinopathyclinicalfeaturesmoleculargeneticsanddirectionsforfuturetherapy